Tarsus Pharmaceuticals (TARS) Long-Term Investments (2022 - 2026)
Tarsus Pharmaceuticals (TARS) reported Long-Term Investments of $6.68 million for Q3 2026, up 122.7% from $3 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Long-Term Investments (2022 - 2026) Analysis & Trends
At the end of FY2025, Tarsus Pharmaceuticals posted Long-Term Investments of $3.87 million, up 29.0% from FY2024.
- Long-Term Investments has increased for three consecutive years, with a three-year compound annual growth rate of 118.5% (FY2022 to FY2025).
- By year, Long-Term Investments came in at $3 million in FY2024 (+375.4%), $631,000 in FY2023 (+70.1%) and $371,000 in FY2022.
- Year over year, Long-Term Investments has now increased in each of the last four quarters, with growth averaging 97.0% over the last seven quarters.
- Across the past five years, year-over-year growth in Long-Term Investments ran from 0.0% in Q2 2025 to 831.7% in Q2 2024.
- Per Business Quant data, the three quarters before Q3 2026 came in at $6.68 million (Q2 2026), $3.87 million (Q1 2026) and $3.87 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 4.01 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 387.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.60 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 63.00 Mn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 268.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 1.45 Bn |
| 10 | Tarsus Pharmaceuticals | 3.64 Bn | 2.07 Bn | 180.68 Mn | 6.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 6.68 Mn |
| Jun 30, 2026 | 6.68 Mn |
| Mar 31, 2026 | 3.87 Mn |
| Dec 31, 2025 | 3.87 Mn |
| Sep 30, 2025 | 3.00 Mn |
| Jun 30, 2025 | 3.00 Mn |
| Mar 31, 2025 | 3.00 Mn |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 3.00 Mn |
| Dec 31, 2023 | 631,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Jun 30, 2023 | 322,000.00 |
| Mar 31, 2023 | 306,000.00 |
| Dec 31, 2022 | 371,000.00 |
| Sep 30, 2022 | 157,000.00 |
| Jun 30, 2022 | 169,000.00 |
API Access
Tarsus Pharmaceuticals Long-Term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-investments&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-investments", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=long-term-investments&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();